Currently browsing: Community News

Day One Biopharmaceuticals

Day One Biopharmaceutical, a start-up biotech company founded with a focus on developing therapies for children with cancer through drug repurposing announced its debut in the market last week.  Its first agent, DAY101, licensed from Takeda Pharmaceuticals, is a targeted treatment for children with low grade glioma, a type of […]

Read more

Community Webinar: G-CSF, Cancer Stem Cells and Relapsed Neuroblastoma: A New Study Opens Up Questions and Opportunities

During our May All-Member and Community webinar, our guest presenter, Dr. Jason Shohet addressed the findings of a new study, “G-CSF Promotes Neuroblastoma Tumorigenicity and Metastasis via STAT3-dependent Cancer Stem Cell Activation” published in the journal Cancer Research that identified a potential link between the use of the ​growth factor’s effect on cancer stem-like […]

Read more

Pediatric Cancer: Major Advances, Major Challenges – Notes from the 5th Annual Childhood Cancer Caucus

The Congressional Childhood Cancer Caucus Presents Pediatric Cancer: Major Advances, Major Challenges 5th Annual Childhood Cancer Caucus Friday, September 19, 2014 9:00 – 10:30 a.m. Congressional Auditorium, US Capitol Visitors Center Co-Chairs: Congressman Michael T. McCaul (R-TX) Congressman Chris Van Hollen (D-MD) Keynote speaker: Dr. Francis Collins, Director, National Institutes […]

Read more

From the Congressional Childhood Cancer Caucus–Concerns about Daunorubicin Shortage

Link to Original on the Congressional Childhood Cancer Caucus website Nov 12, 2013 Caucus Asks Questions about the Ongoing Shortage of Daunorubicin WASHINGTON, D.C. – Out of concern over the ongoing shortage of daunorubicin, an essential therapy in the treatment of leukemia in children, Representatives McCaul and Van Hollen, the co-chairs […]

Read more

Enquire now

Give us a call or fill in the form below and we will contact you. We endeavor to answer all inquiries within 24 hours on business days.